Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Annu Rev Cell Dev Biol. 2000;16:591-626.

SUMO--nonclassical ubiquitin.

Author information

  • Max-Planck Institute for Biochemistry, Am Klopferspitz 18a, Martinsried bei M√ľnchen, D-82152 Germany. melchior@biochem.mpg.de

Abstract

SUMO (small ubiquitin-related modifier) is the best-characterized member of a growing family of ubiquitin-related proteins. It resembles ubiquitin in its structure, its ability to be ligated to other proteins, as well as in the mechanism of ligation. However, in contrast to ubiquitination-often the first step on a one-way road to protein degradation-SUMOlation does not seem to mark proteins for degradation. In fact, SUMO may even function as an antagonist of ubiquitin in the degradation of selected proteins. While most SUMO targets are still at large, available data provide compelling evidence for a role of SUMO in the regulation of protein-protein interactions and/or subcellular localization.

PMID:
11031248
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon
    Loading ...
    Write to the Help Desk